The LGALS7 gene gives instructions for making galectin-7, a protein found mainly in the outer layers of the skin and other protective linings. It helps skin cells stick together, mature normally, and respond to injury. If this gene does not work properly, the skin barrier and wound healing process may be less steady, and normal control of cell growth and cell death can be disrupted. Researchers also study the LGALS7 gene because differences in its activity have been linked to some skin conditions and cancers.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions for making molecules or regulating processes in the body. Some genes carry the code for proteins, which do much of the work inside cells. Others mainly control when certain processes happen, where they occur, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
LGALS7Gene function
What if the gene works
The LGALS7 gene helps make galectin-7, a protein found mainly in the skin and other surface tissues. It helps skin cells grow, stay attached, and repair damage after everyday wear or a wound.
Risk
What if the gene does not work
Changes in the LGALS7 gene can range from milder to more severe and may reduce how well skin cells stick together, mature, and respond to stress. This can disrupt signaling and repair in the outer skin layer.
Treatment
What does that mean for your treatment
No treatment or management approach based on the LGALS7 gene is currently established for people with a pathogenic variant in the LGALS7 gene. In research, galectin 7 is being studied as a biomarker and possible drug target in some cancers and skin conditions, but this has not yet changed routine treatment choices.
Gene function
What if the gene works
Your skin and other body surfaces renew themselves all the time. In these tissues, the LGALS7 gene helps skin cells mature, stay connected, and form an effective outer barrier. Its protein is especially active in layered surfaces such as the skin.
In skin cells, the LGALS7 gene supports the normal steps of cell maturation as cells move toward the surface. This helps the outer layer form in an orderly way.
Its protein attaches to certain sugar molecules on cell surfaces and nearby proteins. This supports cell to cell contact and helps surface tissues stay well organized.
By helping surface cells stay connected and properly arranged, the LGALS7 gene supports the skin’s protective barrier. This barrier helps limit water loss and reduces contact with everyday irritants.
What is a variant?
A genetic variant is a minor difference in a gene's DNA sequence. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and the way the body reacts to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the LGALS7 gene can change galectin-7’s shape, stability, or sugar-binding surface, which may weaken how it interacts with nearby proteins at the cell edge. LGALS7 gene variant effects range from milder changes that slightly reduce binding or folding to more severe variants that cut protein production or create a shortened protein that is quickly cleared. In cellular terms, this can leave less working galectin-7 available and make its signaling and cell-to-cell interaction roles less efficient.
How variants are linked to conditions
The LGALS7 gene does not yet have a broadly confirmed link to a specific health condition, although research on LGALS7 gene variants and health conditions is still evolving. If you carry a confirmed variant in the LGALS7 gene, your doctor or genetic counselor can explain what it may mean for your personal and family history.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural human variation. For many genes, a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce health risk related to the LGALS7 gene. Research has linked changes in LGALS7 activity to some skin and cancer processes, but this has not been turned into clear personal risk rules for everyday care.
Inheritance of LGALS7 variants
There is not yet a broadly confirmed Mendelian inheritance pattern for disease tied specifically to the LGALS7 gene, so a single label such as autosomal dominant or autosomal recessive is not currently used in routine clinical genetics. In practice, questions about how LGALS7 gene variants are inherited do not yet have one established disease based answer. The LGALS7 gene is located on chromosome 19, which is an autosome, so each person inherits one copy from each parent.
What does my LGALS7 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific, recognized inherited condition for LGALS7. If you have a specific LGALS7 result and want to understand what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for the LGALS7 gene looks for variants in DNA from a blood or saliva sample. A lab reads the gene’s sequence and compares it with the usual version to see whether a change is present. Results may show a benign variant, a variant of uncertain significance, or a variant linked to health effects.
When should I consider getting a genetic test?
There is not yet a broadly established, LGALS7-specific reason for genetic testing in routine care. Testing decisions are usually made with a doctor or genetic counselor, based on your health history, family history, and whether broader genetic testing could help answer a medical question.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, yet how much it explains varies depending on the condition and the type of variant present. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can provide a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in a person’s DNA can change how the body breaks down a drug, moves it through the body, or responds to it at the target site. This is common and can help explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics focuses on how differences in genes can shape a person’s response to medicines. By examining links between genes and medications, it helps explain why the same treatment does not work the same way for everyone. With many drugs, genes can influence either how much effect a medicine has or how the body handles it. This information can support treatment choices that are more informed and more tailored to the individual. More detailed information is available in the LearnHub.
Drugs influenced by the LGALS7 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used. Questions about side effects, new symptoms, or whether a treatment is helping are best discussed with your doctor.
History
LGALS7 entered the scientific literature in the 1990s as researchers were mapping members of the galectin family, a group of genes named for their ability to bind certain sugars. It was identified in skin and other layered tissues, which helped set it apart from several related genes. Early papers often referred to its protein product as galectin-7, and that name became the standard in research. From these first observations, research expanded steadily. Later studies connected the LGALS7 gene to epithelial cell biology and to pathways involving the TP53 gene, which increased interest in cancer research. Over time, this work placed LGALS7 within a broader story of how cell stress, skin biology, and tumor studies came together in modern genetics.